Prosecution Insights
Last updated: May 29, 2026
Application No. 18/427,093

PROSTATE MEASUREMENT SYSTEM

Non-Final OA §102§103§112
Filed
Jan 30, 2024
Priority
Jan 30, 2023 — provisional 63/442,042
Examiner
SHAH, JAY B
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medicametrix Inc.
OA Round
1 (Non-Final)
57%
Grant Probability
Moderate
1-2
OA Rounds
1y 1m
Est. Remaining
64%
With Interview

Examiner Intelligence

Grants 57% of resolved cases
57%
Career Allowance Rate
217 granted / 379 resolved
-12.7% vs TC avg
Moderate +7% lift
Without
With
+7.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
30 currently pending
Career history
408
Total Applications
across all art units

Statute-Specific Performance

§101
10.6%
-29.4% vs TC avg
§103
66.8%
+26.8% vs TC avg
§102
4.5%
-35.5% vs TC avg
§112
10.4%
-29.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 379 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 16 is objected to because of the following informalities: Claim 16 recites “wherein the barrier is comprised of a material comprises”. Appropriate correction of this grammatical error is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 (the rest by dependency) recites “a patient’s anatomy” twice. It is unclear of Applicant is referring to two separate patients. Claims 2, 8-12, 14-19 (rest by dependency) recite “the barrier”. It is unclear if Applicant is referring to the “disposable barrier” recited in claim 1 or another barrier. Claim 12 (13 by dependency) recites “the user”. There is insufficient antecedent basis for this limitation. Claim 13 recites “a user”. It is unclear if Applicant is referring to the user recited in claim 12 or another user. Claim 19-20 recite “the insert member”. Is it unclear if applicant is referring to the “rigid insert member” of claim 18 or another insert member. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-4, 11-20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by George et al. (US 20170172486 A1 – cited by Applicant), hereinafter George. Regarding Claim 1, George teaches: A prostate measurement system (figure 1) comprising: a measurement assembly (figure 1; element 104) operably couplable to a control unit (element 106) and comprising a probe configured to collect measurement data associated with a patient's anatomy during an examination procedure (figure 2; paragraph 0114-0118); and a disposable barrier shaped and/or sized to be removably fitted over the probe and provide a sterile layer of protection between a patient's anatomy and the probe during performance of the examination procedure (paragraph 0120; membrane 112; figure 1-2). Regarding Claim 2, George teaches: The prostate measurement system of claim 1, wherein the barrier comprises: a closed distal end shaped and/or sized to fully accommodate the probe within (figure 2); and an open proximal end shaped and/or sized to allow for the probe and portions of the measurement assembly to pass therethrough and to further accommodate a user's hand (figure 2-3). Regarding Claim 3, George teaches: The prostate measurement system of claim 2, wherein the closed distal end comprises an inner diameter that is greater than an outer diameter of the probe (figure 2). Regarding Claim 4, George teaches: The prostate measurement system of claim 3, wherein the closed distal end is shaped and/or sized to fully accommodate the probe within when an inflatable portion of the probe is fully inflated (figure 2; paragraph 0120). Regarding Claim 11, George teaches: The prostate measurement system of claim 1, wherein the barrier comprises a durable material capable of withstanding pressure placed upon the barrier and resisting tearing during performance of the examination procedure (paragraph 0120). Regarding Claim 12, George teaches: The prostate measurement system of claim 1, wherein the barrier comprises a flexible material allowing for sufficient tactile feedback to be felt by the user when the user is performing the examination procedure with the probe (paragraph 0120). Regarding Claim 13, George teaches: The prostate measurement system of claim 12, wherein the probe is configured to be mounted to a user's finger (figure 2) and the probe is to be used in a digital rectal examination (DRE) procedure (paragraph 0179; figure 1). Regarding Claim 14, George teaches: The prostate measurement system of claim 1, wherein the barrier is single use (paragraph 0114). Regarding Claim 15, George teaches: The prostate measurement system of claim 1, wherein the barrier comprises a non-stick material allowing for improved and unobstructed insertion and withdrawal of the probe into and out of the interior of the barrier (paragraph 0120; Vytex is a known non-stick coating). Regarding Claim 16, George teaches: The prostate measurement system of claim 15, wherein the barrier is comprised of a material comprises a coating provided on an interior surface thereof that exhibits non-stick properties (paragraph 0120). Regarding Claim 17, George teaches: The prostate measurement system of claim 1, wherein the barrier further comprises an auto-centering feature for properly positioning a user's finger, upon which the probe is to be mounted, into alignment with the distal end of the barrier (paragraph 0126; 0023; 0021; figures 14-17). Regarding Claim 18, George teaches: The prostate measurement system of claim 17, wherein the auto-centering feature comprises a rigid insert member provided within an interior of the barrier and positioned adjacent to the closed distal end (paragraph 0021 – substrate of polyethylene). Regarding Claim 19, George teaches: The prostate measurement system of claim 18, wherein the insert member is shaped and/or sized to maintain separation of opposing interior surfaces of the barrier at or near an entry point into the distal end (figure 12b; 13). Regarding Claim 20, George teaches: The prostate measurement system of claim 19, wherein the insert member comprises a cutout, void, and/or aperture substantially centered with the distal end and is shaped and/or sized to allow for a user's finger and the probe mounted thereto to pass therethrough and into the distal end (figure 14-17). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 5-10 is/are rejected under 35 U.S.C. 103 as being unpatentable over George. Regarding Claim 5, George teaches: The prostate measurement system of claim 2 but does not explicitly mention wherein the closed distal end comprises a first inner diameter of at least 41 mm and a second inner diameter of at least 101 mm. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date to have modified the system wherein the closed distal end comprises a first inner diameter of at least 41 mm and a second inner diameter of at least 101 mm as it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involve only routine skill in the art (In re Aller, 105 USPQ 233; MPEP 2144.05 II A). Regarding Claim 6, George teaches: The prostate measurement system of claim 2, but does not explicitly mention wherein the closed distal end comprises a length of between 10 cm and 50 cm. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date to have modified the system wherein the closed distal end comprises a length of between 10 cm and 50 cm as it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involve only routine skill in the art (In re Aller, 105 USPQ 233; MPEP 2144.05 II A). Regarding Claim 7, George teaches: The prostate measurement system of claim 6, but does not explicitly mention wherein the closed distal end comprises a length of between 15 cm and 25 cm. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date to have modified the system wherein the closed distal end comprises a length of between 15 cm and 25 cm as it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involve only routine skill in the art (In re Aller, 105 USPQ 233; MPEP 2144.05 II A). Regarding Claim 8, George teaches: The prostate measurement system of claim 2, but does not explicitly mention wherein the barrier comprises an overall length of between 50 cm and 150 cm. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date to have modified the system wherein the barrier comprises an overall length of between 50 cm and 150 cm as it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involve only routine skill in the art (In re Aller, 105 USPQ 233; MPEP 2144.05 II A). Regarding Claim 9, George teaches: The prostate measurement system of claim 7, but does not explicitly mention wherein the barrier comprises an overall length of between 75 cm and 100 cm. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date to have modified the system wherein the barrier comprises an overall length of between 75 cm and 100 cm as it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involve only routine skill in the art (In re Aller, 105 USPQ 233; MPEP 2144.05 II A). Regarding Claim 10, George teaches: The prostate measurement system of claim 8, but does not explicitly mention wherein the barrier comprises an overall length of approximately 90 cm. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date to have modified the system wherein the barrier comprises an overall length of approximately 90 cm as it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involve only routine skill in the art (In re Aller, 105 USPQ 233; MPEP 2144.05 II A). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Wedel et al. US 5088500 A. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAY B SHAH whose telephone number is (571)272-0686. The examiner can normally be reached M-F 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at 571-272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. JAY SHAH Primary Examiner Art Unit 3791 /JAY B SHAH/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Jan 30, 2024
Application Filed
Jan 13, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12629071
METHOD FOR PROVISION OF INFORMATION ON MENTAL DISORDER AND DEVICE FOR PROVISION OF INFORMATION ON MENTAL DISORDER, USING SAME
4y 2m to grant Granted May 19, 2026
Patent 12629054
POSTURE MEASUREMENT SYSTEM FOR REALIGNMENT
2y 6m to grant Granted May 19, 2026
Patent 12622600
SYSTEM AND METHOD FOR MAINSTREAM EXHALED OXYGEN SENSOR
4y 6m to grant Granted May 12, 2026
Patent 12616801
PHLEBOTOMY AID DEVICE
4y 6m to grant Granted May 05, 2026
Patent 12616392
Devices, Methods and Kits for Biological Sample Capture and Processing
3y 7m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
57%
Grant Probability
64%
With Interview (+7.2%)
3y 5m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 379 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month